LivaNova Director Sells 1,650 Shares for $131,500
The insider sold 1,650 shares but still retains nearly 8,000 shares.
Director Francesco Bianchi sold 1,650 shares of LivaNova, a medical technology company valued at $4.3 billion, on August 31, 2026, according to a recent SEC filing. The transaction, valued at $131,500 based on a weighted average sale price of $79.72 per share, was executed in the company's hometown of Gloucester. LivaNova, which employs 3,300 people, generates substantial revenue of $1.5 billion annually, with a net income of $188.6 million, indicating a strong market demand for its innovative devices in cardiac and neuromodulation therapies.
The company's success is attributed to its unique technology, established partnerships with top surgeons, and a diverse product line that meets urgent needs in cardiopulmonary and neurological treatments.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
